Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bonnie Henderson

Ophthalmology Boston, MA Medical Doctor

NPI 1710968953 CMS profile 123795

50 Staniford St, Suite 600, Boston, MA 02114

Open in the dashboard

General payments

$279,316

186 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bonnie Henderson of Boston, MA is reported in the CMS Open Payments database as having received $279,316 across 186 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $286 3
2024 General $26,500 2
2023 General $58,344 7
2022 General $42,975 23
2021 General $31,965 34
2020 General $30,054 15
2019 General $89,192 102

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bonnie Henderson
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Bonnie Henderson were reported at $286. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Bonnie Henderson Ophthalmology median Middle half National median
2019 $89,192 $258 $104–$655 $163
2020 $30,054 $126 $45–$321 $114
2021 $31,965 $205 $76–$534 $132
2022 $42,975 $266 $100–$678 $149
2023 $58,344 $308 $117–$745 $160
2024 $26,500 $340 $127–$846 $164
2025 $286 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb Americas Inc. $98,043 7 payments
  2. Alcon Vision LLC $93,181 92 payments
  3. Alcon Research LLC $41,019 16 payments
  4. Novartis Pharmaceuticals Corporation $25,873 23 payments
  5. Allergan Inc. $7,949 5 payments
  6. Horizon Therapeutics plc $5,481 5 payments
  7. Bausch & Lomb, a division of Bausch Health US, LLC $1,574 7 payments
  8. Carl Zeiss Meditec, Inc. $1,500 1 payment
  9. EyePoint Pharmaceuticals US, Inc. $1,317 2 payments
  10. Kala Pharmaceuticals, Inc. $1,068 5 payments
  11. Other $2,310 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $133,900 15 payments
  2. Consulting Fee $128,220 74 payments
  3. Travel and Lodging $6,960 25 payments
  4. Honoraria $5,292 2 payments
  5. Food and Beverage $4,937 69 payments
  6. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. VYZULTA $73,000 5 payments
  2. MIEBO $62,500 2 payments
  3. LOTEMAX SM $61,579 7 payments
  4. ORA $16,450 15 payments
  5. AcrySof $14,000 14 payments
  6. AcrySof IQ PanOptix Ophthalmology $11,142 10 payments
  7. Capella Aberrometer $10,500 10 payments
  8. AcrySof IQ PanOptix Ophthalmology $10,500 3 payments
  9. AcrySof IQ VIVITY IOL $9,697 8 payments
  10. DUREZOL $8,807 7 payments
  11. Other $40,733 70 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

186 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record